Stock Markets February 2, 2026

InMode Shares Tick Higher as Board Launches Strategic Review

Independent director committee retained advisors to assess potential proposals amid takeover speculation

By Nina Shah INMD SPLP
InMode Shares Tick Higher as Board Launches Strategic Review
INMD SPLP

InMode Ltd. (NASDAQ:INMD) shares rose modestly in Monday premarket trading after the company confirmed it has initiated a formal review of potential strategic alternatives. An independent directors committee has been formed and engaged outside legal and financial advisers to evaluate proposals, though the company cautioned there is no assurance the process will lead to a transaction and provided no timeline or details about options under consideration.

Key Points

  • InMode confirmed it is reviewing potential strategic alternatives and its stock rose 2.5% in Monday premarket trading - impacts equity market participants and investors in medical technology stocks.
  • An independent directors committee has been formed and retained external legal and financial advisers to evaluate proposals - highlights governance and advisory processes relevant to corporate restructurings.
  • Reports cited a non-binding proposal from Steel Partners Holdings L.P. to acquire 51% of outstanding shares; the company stressed there is no guarantee the review will result in a transaction - affects takeover and M&A dynamics in the healthcare equipment sector.

InMode Ltd. (NASDAQ:INMD) saw its stock rise 2.5% in premarket trading on Monday following the company's confirmation that it is conducting a strategic review. The Israel-based medical technology firm said it has set up a committee of independent directors to oversee the evaluation of potential alternatives.

The independent committee has engaged outside legal and financial advisers to assist in assessing any proposals that may be submitted. The company stated the review will consider proposals that could involve third parties or entities affiliated with management.

The announcement arrives amid market conjecture, including reports of a non-binding proposal from Steel Partners Holdings L.P. to acquire 51% of InMode's outstanding shares and recent public statements attributed to the chief executive officer. InMode highlighted that these reports do not change the uncertain nature of the review.

Company management made clear that there is no certainty the review will produce a strategic transaction or alternative outcome. InMode also said it does not intend to provide further comment about the review while it is ongoing unless disclosure is mandated by law or regulation.

No schedule or specific strategic options were disclosed. The company, which develops and manufactures devices that use radio frequency technology for medical procedures, provided no further operational or financial details tied to the review.


Is SPLP a bargain right now? The fastest way to find out is with our Fair Value calculator. The tool uses a mix of 17 industry valuation models to estimate fair value for SPLP and other stocks.


For market participants, the formation of an independent directors committee and the hiring of external advisers are standard governance steps when a company assesses strategic alternatives. InMode's statement reiterates the procedural safeguards - independent oversight and external advice - intended to ensure proposals are evaluated separately from management influence.

That said, the company declined to offer timing or a menu of potential outcomes, leaving investors and counterparties without clarity on the duration or direction of the process. The announcement therefore confirms only the existence of a formal review rather than any imminent change to ownership, operations, or capital structure.

Risks

  • No assurance the strategic review will produce any transaction or strategic outcome - introduces outcome uncertainty for shareholders and counterparties in M&A and capital markets.
  • Company will not comment further on the ongoing process unless required by law or regulation - constrains information flow to investors, potentially increasing short-term volatility in the stock.
  • No timeline or specific options were provided for the review - leaves investors unable to assess timing risk or the potential impact on corporate operations and financing plans.

More from Stock Markets

Quarantine Enforced at Texas Immigration Center After Two Measles Cases Confirmed Feb 2, 2026 Security Flaw in 'Moltbook' Exposed Private Data of Thousands, Cyber Firm Says Feb 2, 2026 Capgemini to Divest U.S. Government Unit Amid Scrutiny Over ICE Contract Feb 2, 2026 Piper Sandler Favors Select Home Improvement Names as Home Equity Activity Rebounds Feb 2, 2026 Ondas to Buy Rotron Aero, Expanding Long-Range Autonomous Strike Capabilities Feb 2, 2026